AstraZeneca admits its COVID vaccine, Covishield, can cause rare side effect – The Times of India

Expand

In 2023, the World Health Organisation (WHO) said in its report that TTS emerged as a new adverse event following immunisation in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines. This refers to the AstraZeneca COVID-19 ChAdOx-1 vaccine and the Johnson & Johnson (J&J) Janssen COVID-19 Ad26.COV2-S vaccines.

Read more from the original source:

AstraZeneca admits its COVID vaccine, Covishield, can cause rare side effect - The Times of India

Related Posts
Tags: